Drug Injury Watch

Side Effects News & Reports

From 2005 to the Present

All Articles by Tom Lamb

Tag: side effects

As Bayer Settlements For YAZ, Yasmin, Ocella, And Gianvi Continue In 2013, Total Payments Will Go Over The $1 Billion Level

March 4, 2013

According To Bayer 2012 Annual Report, More Than 3200 Blood Clot Claims Remain Unsettled And Additional Lawsuits Are Anticipated By Drug Company (Posted by Tom Lamb at DrugInjuryWatch.com)To start, by my review, there is…
Continue reading…
Kidney Dialysis Anemia Drug Recall: Omontys: Hypersensitivity / Allergic Reactions And Anaphylaxis; Serious Side Effects With Some Being Fatal

February 25, 2013

Omontys: Deaths During Initial Injection Within 30 Minutes During Treatment Of Anemia Due To Chronic Kidney Disease In Hemodialysis Patients (Posted by Tom Lamb at DrugInjuryWatch.com)The Omontys (peginesatide) injection was approved in March 2012…
Continue reading…
Should Merck Have Known And Warned About Fosamax Side Effects Involving The Jaw And Femur Bone Problems Starting When This Drug Was First Put On Market In 1995

February 8, 2013

Intriguing New Medical/Chemical Journal Article Contends That Medicinal Chemists Or Pharmacologists At The Drug Company Could Have Anticipated Bisphosphonate-Related ONJ And Femur Fracture Cases (Posted by Tom Lamb at DrugInjuryWatch.com)In January 2013 the ACS Medicinal…
Continue reading…
Atypical Femur Fractures: Due To Fosamax Or A Bisphosphonates Drug Class Side Effect?

January 15, 2013

Is The Fact That Fosamax Has Been The Most Prescribed — More Often Than Actonel, Aredia, Boniva, Etc. – Blurring The Answer To This Drug-Safety Issue? (Posted by Tom Lamb at DrugInjuryWatch.com)In June 2012 the…
Continue reading…
Some Newer Contraceptive Methods Such As NuvaRing And YAZ / Yasmin Are Under Increasing Scrutiny Over In Europe

January 4, 2013

Is The FDA Doing Enough About Birth Control Products That Contain Third Generation Or Fourth Generation Progestins And Are Associated With Higher Risks Of Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) A January 3,…
Continue reading…
December 2012 Pradaxa Update: Prescription / Sales Numbers And Drug Company Safety Study Results

December 10, 2012

It Has Been Far From Smooth Sailing For Pradaxa During The Two Years It Has Been Available In The United States (Posted by Tom Lamb at DrugInjuryWatch.com) As we reported in this earlier article,…
Continue reading…
Generic Drugs Post-Mensing Ruling: One Proposed Solution To The Legal Compensation And FDA Drug Safety Problems Supreme Court Created

December 3, 2012

At Least, This November 2012 Article In The New England Journal Of Medicine Makes The Point That Something Needs To Be Done Soon, Rather Than Later (Posted by Tom Lamb at DrugInjuryWatch.com) The June 2011…
Continue reading…
The Drug-Induced Pancreatitis Safety Problem That Hangs Around Victoza Gets Another Look

November 15, 2012

The Relatively New Diabetes Medication Victoza From Novo Nordisk Was Only Approved By FDA In 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) In November 2012 The Annals of Pharmacotherapy published online before print this new…
Continue reading…
Pradaxa Safety Debate Continues During November 2012 With Many Different Conclusions And Positions

November 9, 2012

While Doctors And Hospitals Handle Patients Having Serious Bleeding Events From Pradaxa, The Drug Company Along With The FDA Still Say All Is Fine, Here (Posted by Tom Lamb at DrugInjuryWatch.com) There was a flurry of activity in the…
Continue reading…
New Obesity Drug Qsymia / Qsiva Gets Gets Negative Opinion By European Medicines Agency (EMA)

October 22, 2012

Combination Pill Of Topamax And Phentremine Was Approved By FDA, But EMA Points To Heart Side Effects, Birth Defects, And Other Safety Issues (Posted by Tom Lamb at DrugInjuryWatch.com) On October 18, 2012 European drug regulators…
Continue reading…